The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
Abstract
The utility of recombinant adenovirus serotype 5 (rAd5) vector-based vaccines for HIV-1 and other pathogens will likely be limited by the high prevalence of pre-existing Ad5-specific neutralizing Abs (NAbs) in human populations. However, the immunodominant targets of Ad5-specific NAbs in humans remain poorly characterized. In this study, we assess the titers and primary determinants of Ad5-specific NAbs in individuals from both the United States and the developing world. Importantly, median Ad5-specific NAb titers were >10-fold higher in sub-Saharan Africa compared with the United States. Moreover, hexon-specific NAb titers were 4- to 10-fold higher than fiber-specific NAb titers in these cohorts by virus neutralization assays using capsid chimeric viruses. We next performed adoptive transfer studies in mice to evaluate the functional capacity of hexon- and fiber-specific NAbs to suppress the immunogenicity of a prototype rAd5-Env vaccine. Hexon-specific NAbs were remarkably efficient at suppressing Env-specific immune responses elicited by the rAd5 vaccine. In contrast, fiber-specific NAbs exerted only minimal suppressive effects on rAd5 vaccine immunogenicity. These data demonstrate that functionally significant Ad5-specific NAbs are directed primarily against the Ad5 hexon protein in both humans and mice. These studies suggest a potential strategy for engineering novel Ad5 vectors to evade dominant Ad5-specific NAbs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Self-citationShiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Self-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
Vogels, R., Zuijdgeest, D., van Rijnsoever, R., Hartkoorn, E., Damen, I., de Béthune, M.-P., Kostense, S., Penders, G., Helmus, N., Koudstaal, W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8263-8271.2003 · Cited by 467
Self-citationAccelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z.-Y., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 462
Casimiro, D. R., Chen, L., Fu, T.-M., Evans, R. K., Caulfield, M. J., Davies, M.-E., Tang, A., Chen, M., Huang, L., Harris, V., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6305-6313.2003 · Cited by 400
Barouch, D. H., Pau, M. G., Custers, J. H. H. V., Koudstaal, W., Kostense, S., Havenga, M. J. E., Truitt, D. M., Sumida, S. M., Kishko, M. G., Arthur, J. C., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6290 · Cited by 383
Self-citationCrawford-Miksza, L., & Schnurr, D. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1836-1844.1996 · Cited by 325
Shiver, J. W., & Emini, E. A. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104344 · Cited by 280
Replication-Defective Vector Based on a Chimpanzee Adenovirus
Farina, S. F., Gao, G.-P., Xiang, Z. Q., Rux, J. J., Burnett, R. M., Alvira, M. R., Marsh, J., Ertl, H. C. J., & Wilson, J. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11603-11613.2001 · Cited by 272
A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag
Fitzgerald, J. C., Gao, G.-P., Reyes-Sandoval, A., Pavlakis, G. N., Xiang, Z. Q., Wlazlo, A. P., Giles-Davis, W., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1416 · Cited by 216
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms
Wohlfart, C. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2321-2328.1988 · Cited by 216
Overcoming Immunity to a Viral Vaccine by DNA Priming before Vector Boosting
Yang, Z.-Y., Wyatt, L. S., Kong, W.-P., Moodie, Z., Moss, B., & Nabel, G. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.1.799-803.2003 · Cited by 204
Xiang, Z., Gao, G., Reyes-Sandoval, A., Cohen, C. J., Li, Y., Bergelson, J. M., Wilson, J. M., & Ertl, H. C. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2667-2675.2002 · Cited by 195
Exploiting the Natural Diversity in Adenovirus Tropism for Therapy and Prevention of Disease
Havenga, M. J. E., Lemckert, A. A. C., Ophorst, O. J. A. E., van Meijer, M., Germeraad, W. T. V., Grimbergen, J., van den Doel, M. A., Vogels, R., van Deutekom, J., Janson, A. A. M., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.9.4612-4620.2002 · Cited by 192
Self-citationSprangers, M. C., Lakhai, W., Koudstaal, W., Verhoeven, M., Koel, B. F., Vogels, R., Goudsmit, J., Havenga, M. J. E., & Kostense, S. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5046-5052.2003 · Cited by 188
Self-citationChallenges and opportunities for development of an AIDS vaccine
Nabel, G. J. (2001) · Nature · doi:10.1038/35073500 · Cited by 183
Prospects for Vaccine Protection Against HIV-1 Infection and AIDS
Letvin, N. L., Barouch, D. H., & Montefiori, D. C. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.094854 · Cited by 179
Self-citationSumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Koudstaal, W., Pau, M. G., Kostense, S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2666-2673.2004 · Cited by 171
Self-citationRea, D., Havenga, M. J. E., van den Assem, M., Sutmuller, R. P. M., Lemckert, A., Hoeben, R. C., Bout, A., Melief, C. J. M., & Offringa, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5236 · Cited by 158
Self-citationPotent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
Barouch, D. H., Santra, S., Tenner-Racz, K., Racz, P., Kuroda, M. J., Schmitz, J. E., Jackson, S. S., Lifton, M. A., Freed, D. C., Perry, H. C., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.562 · Cited by 158
Self-citationAdenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
Kostense, S., Koudstaal, W., Sprangers, M., Weverling, G. J., Penders, G., Helmus, N., Vogels, R., Bakker, M. E., Berkhout, B., Havenga, M. J. E., et al. (2004) · AIDS · doi:10.1097/00002030-200405210-00019 · Cited by 156
Self-citationInduction of Broadly Cross-Reactive Cytotoxic T Cells Recognizing an HIV-1 Envelope Determinant
Takahashi, H., Nakagawa, Y., Pendleton, C. D., et al. (1992) · Science · doi:10.1126/science.1372448 · Cited by 136
Barouch, D. H., McKay, P. F., Sumida, S. M., Santra, S., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Chakrabarti, B. K., Xu, L., Nabel, G. J., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8729-8735.2003 · Cited by 122
Self-citationAntipeptide antisera define neutralizing epitopes on the adenovirus hexon
Toogood, C. I. A., Crompton, J. L., & Hay, R. T. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-6-1429 · Cited by 117
Pinto, A. R., Fitzgerald, J. C., Giles‐Davis, W., Gao, G. P., Wilson, J. M., & Ertl, H. C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6774 · Cited by 113
Circumvention of Immunity to the Adenovirus Major Coat Protein Hexon
Roy, S., Shirley, P. S., McClelland, A., & Kaleko, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6875-6879.1998 · Cited by 111
Gall, J. G. D., Crystal, R. G., & Falck-Pedersen, E. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10260-10264.1998 · Cited by 105
Hong, S. S., Habib, N. A., Franqueville, L., Jensen, S., & Boulanger, P. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10366-10375.2003 · Cited by 90
Hexon Gene Switch Strategy for the Generation of Chimeric Recombinant Adenovirus
Youil, R., Toner, T. J., Su, Q., Chen, M., Tang, A., Bett, A. J., & Casimiro, D. R. (2002) · Human Gene Therapy · doi:10.1089/10430340252769824 · Cited by 87
Ophorst, O. J. A. E., Kostense, S., Goudsmit, J., de Swart, R. L., Verhaagh, S., Zakhartchouk, A. N., van Meijer, M., Sprangers, M., van Amerongen, G., Yüksel, S., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.011 · Cited by 78
Self-citation
Cited by
Adenovirus Serotype 5 Hexon Mediates Liver Gene Transfer
Waddington, S. N., McVey, J. H., Bhella, D., Parker, A. L., Barker, K., Atoda, H., Pink, R., Buckley, S. M. K., Greig, J. A., Denby, L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.01.016 · Cited by 643
Self-citationAdenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
Abbink, P., Lemckert, A. A. C., Ewald, B. A., Lynch, D. M., Denholtz, M., Smits, S., Holterman, L., Damen, I., Vogels, R., Thorner, A. R., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02696-06 · Cited by 503
Self-citationHexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
Roberts, D. M., Nanda, A., Havenga, M. J. E., Abbink, P., Lynch, D. M., Ewald, B. A., Liu, J., Thorner, A. R., Swanson, P. E., Gorgone, D. A., et al. (2006) · Nature · doi:10.1038/nature04721 · Cited by 491
Self-citationAdenoviruses: update on structure and function
Russell, W. C. (2009) · Journal of General Virology · doi:10.1099/vir.0.003087-0 · Cited by 461
Metadata
- Authors
- Sumida, S. M., Truitt, D. M., Lemckert, A. A. C., Vogels, R., Custers, J. H. H. V., Addo, M. M., Lockman, S., Peter, T., Peyerl, F. W., Kishko, M. G., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Essex, M., Walker, B. D., Goudsmit, J., Havenga, M. J. E., & Barouch, D. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-01
- Volume
- 174
- Issue
- 11
- Pages
- 7179-7185
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2164806280
- Cited by
- 369
- References
- 31
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.